Cardiogenic Shock
Conditions
Brief summary
International, observational registry to investigate the outcome in patients with cardiogenic shock. The primary aim of this study is to investigate the clinical outcome of patients in cardiogenic shock.
Detailed description
There is a focus on interventional therapies, mechanical circulatory support and new cardiovascular therapeutics in patients with cardiogenic shock (CS). The investigators will describe current practice in study sites including concomitant patients with CS. Therefore, the investigators will monitor drug therapies initiated, devices being utilized as well as outcome and side effect of possible interventions
Interventions
None listed
Sponsors
Universitätsklinikum Hamburg-Eppendorf
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients with cardiogenic shock treated at a tertiary care hospital.
Exclusion criteria
* Age ≤17 years.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| All-cause mortality | Within 30 days after admission. | by registration office |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Ischemic events, bleeding events, heart failure, sepsis, dialysis. | Within 30 days after admission. | by survey, number of ischemic events, number of bleeding events, number of patients developing heart failure as well as heart failure severity (NYHA), patients developing terminal kidney failure requiring dialysis. |
| All-cause mortality | Within 12 months after admission. | by registration office |
Countries
Germany
Contacts
Primary ContactBenedikt Schrage, MD
Backup ContactDirk Westermann, MD
Outcome results
None listed